Specimen transport market seen reaching $3.94 billion by 2030

The specimen transport solutions market is forecast to nearly double by 2030 as diagnostic testing, personalized medicine and cold-chain logistics reshape how biological samples move between collection sites and labs. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - The specimen transport solutions market sits at the center of diagnostic testing quality, because sample integrity, temperature control and traceability affect whether lab results are reliable. - Growth in this market tracks broader healthcare demand, including more testing, more biobanking and more clinical research. - Faster, safer sample movement also supports personalized medicine and outsourced laboratory services.

What happened: - The market is projected to rise from $2.43 billion in 2025 to $2.67 billion in 2026. - The forecast implies a 9.9% compound annual growth rate in the near term. - The market is expected to reach $3.94 billion by 2030. - The longer-term outlook points to a 10.2% annual growth rate through 2030. - The Business Research Company published the forecast on July 22, 2026.

The details: - Specimen transport solutions include the methods, technologies and systems used to move biological samples from collection sites to testing laboratories. - These systems are designed to maintain sample integrity, stability and traceability during transit. - The market’s recent expansion reflects a lack of standardized transport procedures, stronger demand for dependable diagnostic testing, expansion of clinical lab networks, greater awareness of contamination risks and early adoption of cold-chain logistics in healthcare. - Future growth is expected to be supported by demand for precise diagnostics and personalized medicine, wider use of digital tracking and IoT monitoring, growth in biobanking and clinical research, outsourcing of lab testing services and advances in automated temperature-controlled logistics. - Key trends include temperature-regulated transport systems, IoT-enabled real-time tracking, tamper-proof and traceable packaging, cold-chain logistics for biological materials and automated specimen transfer between laboratories. - The report says North America held the largest market share in 2025. - The report also says Asia-Pacific is forecast to be the fastest-growing region. - The regional scope includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report offers a free sample and the full market report.

Between the lines: - The forecast suggests specimen transport is shifting from a back-office logistics function to a more technology-heavy part of the diagnostics supply chain. - Demand for tracking, temperature control and tamper resistance points to higher expectations for compliance and sample security. - The regional split signals a mature North American market and a faster-growth opportunity in Asia-Pacific. - The diagnostic testing example in the release underscores the link between more imaging and lab activity and higher sample-handling demand. - England conducted 45.0 million imaging tests in the year ending March 2023, up 2.2% from the prior year, according to the UK National Health Service. - That total included 10.3 million diagnostic ultrasounds, 7.1 million CT scans and 4.1 million MRI scans.

What's next: - Market growth will likely hinge on how quickly healthcare providers adopt connected tracking, automated handling and temperature-controlled transport. - Lab networks and diagnostic operators may continue to invest in systems that reduce delays, errors and contamination risk. - The report frames 2030 as the next major checkpoint for category growth and regional expansion.

The bottom line: - Specimen transport is becoming a bigger, more digital part of diagnostics, and the market is on track for sustained double-digit growth through 2030.